| SC 13G/A | 2024-04-10 | FMR LLC | Regulus Therapeutics Inc. | 2,922,600 | 4.5% | EDGAR |
| SC 13G | 2024-03-25 | RA CAPITAL MANAGEMENT, L.P. | Regulus Therapeutics Inc. | 6,250,000 | 9.5% | EDGAR |
| SC 13G | 2024-03-22 | Deep Track Capital, LP | Regulus Therapeutics Inc. | 6,888,424 | 10.0% | EDGAR |
| SC 13G | 2024-03-20 | Vivo Opportunity Fund Holdings, L.P. | Regulus Therapeutics Inc. | 5,000,000 | 7.7% | EDGAR |
| SC 13D/A | 2024-03-18 | Growth Equity Opportunities V, LLC | Regulus Therapeutics Inc. | 6,533,102 | 10.0% | EDGAR |
| SC 13G | 2024-02-14 | DAFNA Capital Management LLC | Regulus Therapeutics Inc. | 1,111,049 | 5.5% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Regulus Therapeutics Inc. | 2,922,600 | 14.5% | EDGAR |
| SC 13G/A | 2024-02-06 | VICTORY CAPITAL MANAGEMENT INC | Regulus Therapeutics Inc. | 1,155,516 | 5.7% | EDGAR |
| SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | Regulus Therapeutics Inc. | 4,023,860 | 19.9% | EDGAR |
| SC 13D/A | 2023-05-12 | Growth Equity Opportunities V, LLC | Regulus Therapeutics Inc. | 1,945,579 | 10.0% | EDGAR |
| SC 13G/A | 2023-05-10 | FEDERATED HERMES, INC. | Regulus Therapeutics Inc. | 3,875,578 | 19.9% | EDGAR |
| SC 13G/A | 2023-02-01 | FEDERATED HERMES, INC. | Regulus Therapeutics Inc. | 2,904,826 | 17.2% | EDGAR |
| SC 13G/A | 2023-01-31 | VICTORY CAPITAL MANAGEMENT INC | Regulus Therapeutics Inc. | 850,197 | 5.0% | EDGAR |
| SC 13G | 2022-10-11 | FMR LLC | Regulus Therapeutics Inc. | 2,195,000 | 15.0% | EDGAR |
| SC 13G | 2022-05-16 | FEDERATED HERMES, INC. | Regulus Therapeutics Inc. | 29,048,265 | 19.9% | EDGAR |
| SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Regulus Therapeutics Inc. | 2,411,577 | 1.6% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Regulus Therapeutics Inc. | 5,174,517 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-14 | EcoR1 Capital, LLC | Regulus Therapeutics Inc. | 2,538,970 | 1.7% | EDGAR |
| SC 13G/A | 2022-02-14 | Altium Capital Management LP | Regulus Therapeutics Inc. | 1,327,801 | 2.1% | EDGAR |
| SC 13G/A | 2022-02-02 | VICTORY CAPITAL MANAGEMENT INC | Regulus Therapeutics Inc. | 8,503,643 | 5.8% | EDGAR |